These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 25683625

  • 1. A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome.
    Id Said B, Malkin D.
    Cancer Genet; 2015; 208(1-2):47-51. PubMed ID: 25683625
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.
    Ponti F, Corsini S, Gnoli M, Pedrini E, Mordenti M, Sangiorgi L.
    Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143
    [Abstract] [Full Text] [Related]

  • 3. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.
    Ruijs MW, Schmidt MK, Nevanlinna H, Tommiska J, Aittomäki K, Pruntel R, Verhoef S, Van't Veer LJ.
    Eur J Hum Genet; 2007 Jan; 15(1):110-4. PubMed ID: 17003841
    [Abstract] [Full Text] [Related]

  • 4. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis.
    Marcel V, Palmero EI, Falagan-Lotsch P, Martel-Planche G, Ashton-Prolla P, Olivier M, Brentani RR, Hainaut P, Achatz MI.
    J Med Genet; 2009 Nov; 46(11):766-72. PubMed ID: 19542078
    [Abstract] [Full Text] [Related]

  • 5. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS, Vieira IA, Vianna FSL, Alemar B, Giacomazzi J, Brandalize APC, Caleffi M, Volc SM, de Campos Reis Galvão H, Palmero EI, Achatz MI, Ashton-Prolla P.
    Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
    [Abstract] [Full Text] [Related]

  • 6. MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
    Bandeira IC, Vieira IA, Andreis TF, Brussa Reis L, Macedo GS, Vianna FSL, Santos-Silva P, Palmero EI, Galvão HCR, Ramos CRN, Santiago KM, Achatz MI, da Costa AABA, Ashton-Prolla P.
    Cancer Genet; 2020 Jan; 240():54-58. PubMed ID: 31778928
    [Abstract] [Full Text] [Related]

  • 7. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.
    Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, Amos CI, Shete S, Strong LC.
    Hum Genet; 2011 Jun; 129(6):663-73. PubMed ID: 21305319
    [Abstract] [Full Text] [Related]

  • 8. Functional pri-miR-34b/c rs4938723 and KRAS 3'UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?
    Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, Siebert M, Miyamoto KN, Siqueira MB, Achatz MI, Galvão HCR, Garcia FAO, Campacci N, Carraro DM, Formiga MN, Vianna FSL, Palmero EI, Macedo GS, Ashton-Prolla P.
    Gene; 2024 Mar 10; 898():148069. PubMed ID: 38070788
    [Abstract] [Full Text] [Related]

  • 9. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun 10; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 10. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W, Arai Y, Kasai F, Fujiwara Y, Haruta M, Hosaka R, Nishida K, Kurosumi M, Kobayashi Y, Akagi K, Kaneko Y.
    Genes Chromosomes Cancer; 2011 Jul 10; 50(7):535-45. PubMed ID: 21484931
    [Abstract] [Full Text] [Related]

  • 11. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.
    Cancer; 2013 Dec 15; 119(24):4341-9. PubMed ID: 24122735
    [Abstract] [Full Text] [Related]

  • 12. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
    Macedo GS, Araujo Vieira I, Brandalize AP, Giacomazzi J, Inez Palmero E, Volc S, Rodrigues Paixão-Côrtes V, Caleffi M, Silva Alves M, Achatz MI, Hainaut P, Ashton-Prolla P.
    Cancer Genet; 2016 Mar 15; 209(3):97-106. PubMed ID: 26823150
    [Abstract] [Full Text] [Related]

  • 13. Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
    Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L, Chompret A, Bressac-de Paillerets B, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg T.
    J Med Genet; 2006 Jun 15; 43(6):531-3. PubMed ID: 16258005
    [Abstract] [Full Text] [Related]

  • 14. Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.
    Id Said B, Kim H, Tran J, Novokmet A, Malkin D.
    Hum Mutat; 2016 Sep 15; 37(9):889-92. PubMed ID: 27297285
    [Abstract] [Full Text] [Related]

  • 15. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.
    Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.
    Curr Opin Oncol; 2010 Jan 15; 22(1):64-9. PubMed ID: 19952748
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers.
    Powers J, Pinto EM, Barnoud T, Leung JC, Martynyuk T, Kossenkov AV, Philips AH, Desai H, Hausler R, Kelly G, Le AN, Li MM, MacFarland SP, Pyle LC, Zelley K, Nathanson KL, Domchek SM, Slavin TP, Weitzel JN, Stopfer JE, Garber JE, Joseph V, Offit K, Dolinsky JS, Gutierrez S, McGoldrick K, Couch FJ, Levin B, Edelman MC, Levy CF, Spunt SL, Kriwacki RW, Zambetti GP, Ribeiro RC, Murphy ME, Maxwell KN.
    Cancer Res; 2020 Sep 01; 80(17):3732-3744. PubMed ID: 32675277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.